↓ Skip to main content

Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease

Overview of attention for article published in Cochrane database of systematic reviews, January 2007
Altmetric Badge

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
15 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease
Published in
Cochrane database of systematic reviews, January 2007
DOI 10.1002/14651858.cd006007.pub2
Pubmed ID
Abstract

Upper gastrointestinal bleeding is one of the most frequent causes of morbidity and mortality in the course of liver cirrhosis. Patients with liver disease frequently have haemostatic abnormalities, which include accelerated fibrinolysis. Several primary treatments are used for upper gastrointestinal bleeding in patients with liver diseases. Supplementary interventions are often used as well. One of them could be antifibrinolytic amino acids administration.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 3 20%
Student > Bachelor 2 13%
Librarian 2 13%
Student > Ph. D. Student 2 13%
Lecturer 1 7%
Other 3 20%
Unknown 2 13%
Readers by discipline Count As %
Medicine and Dentistry 8 53%
Social Sciences 2 13%
Biochemistry, Genetics and Molecular Biology 1 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Psychology 1 7%
Other 0 0%
Unknown 2 13%